miR-496 mimic

miR-496 mimic is a research-stage synthetic double-stranded RNA molecule designed to mimic the endogenous microRNA miR-496. In preclinical studies, particularly in gastric cancer and triple-negative breast cancer, miR-496 mimic has been shown to inhibit cell proliferation, migration, and invasion, and to induce apoptosis. It exerts its effects primarily by targeting LYN kinase (LYN) and suppressing the downstream AKT/mTOR signaling pathway, as well as targeting developmentally regulated endothelial cell locus 1 (Del-1/EDIL3). The compound is primarily sourced from reagent suppliers such as GenePharma and MedChemExpress for laboratory research, and there is no formal clinical development program or approved therapeutic indication associated with it.

Other names

hsa-miR-496 agomirhsa-miR496 agomirhsa-miR 496 agomirhsa-miR-496 mimichsa-miR496 mimichsa-miR 496 mimicmicroRNA-496 mimicmicroRNA496 mimicmicroRNA 496 mimicmiR-496 agomirmiR496 agomirmiR 496 agomir